Dr. Joshua Allen, PhD serves as Director of Development at Oncoceutics, Inc. In 2016, Dr. Allen was selected as one of Forbes' 30 Under 30 Healthcare honorees.

Dr. Allen has relevant drug development skills that include high-throughput screening, in silico analysis, animal models, combination therapy, cell signaling, cell death, biomarkers, and correlative assays.

Dr. Allen has several publications regarding drug discovery and development as well as biomarkers in oncology with an emphasis on understanding and targeting the TRAIL pathway for therapeutic intervention in cancer.

Dr. Allen received his Ph.D. in Biochemistry and Molecular Biophysics from the University of Pennsylvania and completed a post-doctoral fellowship at the Penn State Cancer Institute.

Cancer, Researcher, Research scientist Health, Oncology, Healthcare, Forbes Top Lists, Breast Cancer Research & Education, Breast Cancer, Breast Cancer Awareness Month,